Article
Cromolyn Sodium Therapy in Childhood Asthma
Abstract
AbstractThirty children, ages of 6 to 16 years, with severe perennial asthma, were subjects in a double-blind, crossover study designed to evaluate the effectiveness of cromolyn sodium therapy for childhood asthma. Assessment of drug effectiveness was based upon comparisons of daily ratings of severity of wheezing and need for additional medications (bronchodilators and steroids). Of the 26 patients completing the study, 16 (62%) placed on cromolyn sodium therapy had at least a 50% lower wheeze score, compared to only two (8%) receiving placebo (p.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.